Mifepristone Tablet
Product Images NDC 76346-654

2 FDA label images from Corcept Therapeutics Incorporated · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mifepristone (NDC 76346-654). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Corcept Therapeutics Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mif00 0003 01)

Structural Formula (Mif00 0003 01)
Chemical structure diagram of mifepristone, showing its detailed molecular framework including rings and side chains.*
FDA Label Image

Principal Display Panel (for 280 Tablets Bottle Label (2000017691))

Principal Display Panel (for 280 Tablets Bottle Label (2000017691))
Label for Mifepristone 300 mg tablets, oral dosage form, containing 280 tablets per package. The label specifies each yellow oval-shaped tablet contains 300 mg of mifepristone and instructs to take tablets whole without splitting, crushing, or chewing. It is manufactured by Corcept Therapeutics Incorporated in Redwood City, CA, and includes storage instructions and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.